MPM BioImpact LLC - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 251 filers reported holding CYTOKINETICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.

Quarter-by-quarter ownership
MPM BioImpact LLC ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2022$9,361,000
+22.7%
193,205
-0.5%
2.22%
+4.6%
Q2 2022$7,632,000
-7.5%
194,246
-13.4%
2.12%
-4.3%
Q1 2022$8,254,000
-22.0%
224,246
-3.5%
2.22%
+14.8%
Q4 2021$10,587,000
+19.8%
232,268
-6.1%
1.93%
+40.8%
Q3 2021$8,838,000247,2911.37%
Other shareholders
CYTOKINETICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 223,382$6,580,8347.72%
Finepoint Capital LP 431,693$12,717,6766.33%
Saturn V Capital Management LP 495,168$14,587,6496.11%
Logos Global Management LP 1,250,000$36,825,0004.91%
DAFNA Capital Management LLC 479,538$14,127,1894.39%
PFM Health Sciences, LP 2,399,545$70,690,5963.33%
Boxer Capital, LLC 2,100,000$61,866,0003.29%
Integral Health Asset Management, LLC 800,000$23,568,0003.26%
GREAT POINT PARTNERS LLC 600,000$17,676,0003.22%
Nicholas Investment Partners, LP 942,137$27,755,3562.07%
View complete list of CYTOKINETICS INC shareholders